Jaguar Health, Inc. (JAGX): Nasdaq/NYSE listing notice — Jaguar Health receives Nasdaq delisting notice for bid price below $1.00

Jaguar Health, Inc.

Nasdaq notified Jaguar Health on May 10, 2023, that its stock's bid price closed below $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2).
Company granted 180-day grace period until November 6, 2023, to regain compliance by achieving closing bid price of at least $1.00 for 10 consecutive business days.
If not compliant by Nov 6, Nasdaq may grant a second 180-day period if the company meets other initial listing standards, including stockholders' equity of at least $5 million (current condition).
Jaguar Health states it is diligently working to evidence compliance but cannot assure regaining compliance or extension.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Jaguar Health, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 10, 2023, Jaguar Health, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the bid price for the Company’s common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180 calendar day grace period, or until November 6, 2023, to regain compliance with the minimum bid price requirement. The continued listing standard

View on SEC.gov

Browse all listing & compliance notices →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-059841

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.